作为链接全球贸易资源、构建开放型世界经济的重要桥梁，中国国际进口博览会（进博会）不仅是展现 中国市场活力的重要窗口，也已成为促进国内外产业深度融合的核心枢纽。它持续搭建供需对接的高效 平台，为全球贸易的稳定发展注入持久动力。 自2018年首次举办以来，进博会让展品变商品、让展商变投资商，国际采购、投资促进、人文交流、开 放合作四大平台作用日益凸显。对于不少企业来说，进博会的意义早已超出产品展示。作为进博会的老 朋友，葛兰素史克（GSK）连续八年以"全勤生"的身份持续投身其中，推动自身从中国经济发展的"见 证者"转变为"参与者"和"推动者"。 在全球医药创新格局深度调整的背景下，进博会已成为中国展现医药领域开放包容姿态的重要窗口。通 过这一平台，跨国药企的创新药械得以快速触达中国患者，中外医药创新资源实现高效对接，为中国医 药产业的高质量发展注入了活力。这一开放共赢的生态，也让跨国药企更加看好中国市场的发展潜力， 坚定了其长期布局的战略选择。 "进博会为我们的创新成果提供了重要的放大效应。作为全球新技术、新产品'首发首秀'的重要平台， 它让我们众多创新药品及医疗解决方案得以在上市前便与公众见面，更能与政府部门及 ...

Core Viewpoint - The China International Import Expo (CIIE) serves as a vital bridge for global trade resources and an important platform for deep integration of domestic and international industries, showcasing China's market vitality and promoting stable global trade development [1][3]. Group 1: CIIE's Role and Impact - Since its inception in 2018, CIIE has transformed exhibits into commodities and exhibitors into investors, highlighting its roles in international procurement, investment promotion, cultural exchange, and open cooperation [3]. - GSK has participated in CIIE for eight consecutive years, evolving from a witness to a participant and promoter of China's economic development [3]. - GSK's Vice President emphasized CIIE's high-quality platform advantage and its role as a significant showcase of China's reform, opening up, and high-quality development achievements [3]. Group 2: GSK's Commitment to China - GSK views China as a crucial strategic market and believes it has become a core growth engine and a significant source of global innovation [5]. - The rapid growth of China's innovative pharmaceutical sector has positioned the country as a key player in global pharmaceutical innovation, injecting new vitality into the industry [7]. - GSK's commitment to China includes establishing a global innovation center and aligning its product pipeline with China's health strategies [11]. Group 3: Innovation and Collaboration - CIIE provides a platform for GSK to showcase innovative products and solutions, facilitating deep communication with government and industry partners to accelerate the implementation of innovations in China [9]. - GSK plans to present around 20 innovative products at this year's CIIE, focusing on areas such as respiratory and immune diseases, infections, vaccines, and oncology [9]. - GSK is actively collaborating with local partners to enhance the accessibility of its products and to explore innovative healthcare models in China [12]. Group 4: Future Outlook - GSK anticipates that breakthroughs in biopharmaceuticals and artificial intelligence in China will have a profound impact on the global pharmaceutical industry [5]. - The company aims to deepen its engagement in high-quality industry discussions and expand its network to uncover more collaboration opportunities [11]. - GSK is committed to integrating global resources with local advantages to foster an open and win-win industrial ecosystem in China [13].